| Financial Year |
March 31 2023 |
| Monetary Funds |
979,080,296.27 |
| Held-for-trading Financial Assets |
278,069,627.03 |
| Notes Receivable |
240,129,635.50 |
| Accounts Receivable |
2,031,449,474.82 |
| Advances to Suppliers |
102,324,483.84 |
| Other Receivables |
36,239,809.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
731,967.78 |
| Dividend Receivable |
-- |
| Inventories |
1,256,584,234.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
99,853,607.57 |
| Total Current Assets |
5,373,946,872.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,259,878.88 |
| Investment Properties |
-- |
| Fixed Assetes |
444,069,961.00 |
| Under-construction Projects |
328,490,522.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
322,596,442.11 |
| R&D expenses |
-- |
| Goodwill |
106,011,447.45 |
| Long-Term Deferred and Prepaid Expenses |
16,597,010.21 |
| Deferred Income Tax Assets |
89,852,565.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,363,560,532.30 |
| Total Assets |
6,737,507,405.23 |
| Short-Term Loans |
748,652,430.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
392,371,142.16 |
| Accounts Payable |
901,246,502.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,358,152.89 |
| Taxes Payable |
60,388,771.37 |
| Interest Payable |
2,192,804.75 |
| Dividend Payable |
-- |
| Other payables |
81,904,586.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,067,334.67 |
| Other Current Liabilities |
379,886,659.44 |
| Sub-Total of Current Liabilities |
3,380,992,023.35 |
| Long-term Loans |
218,119,240.51 |
| Bonds Payable |
632,393,997.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
25,706,486.77 |
| Deferred Income Tax Liabilities |
9,156,663.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
941,691,341.37 |
| Total Liabilities |
4,322,683,364.72 |
| Paid-In Capital(Or Share Stock) |
425,418,634.00 |
| Capital Surplus |
720,926,792.89 |
| Surplus Reserve |
114,869,878.77 |
| LESS:Treasury Stock |
34,348,089.48 |
| Undistributed Profits |
1,044,178,304.55 |
| Minority Stockholder's Interest |
61,044,660.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,353,779,379.56 |
| Owner's Equity（Stockholder's Equity） |
2,414,824,040.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,737,507,405.23 |
